STAT+: For prostate cancer patients set on surgery, new hormone regimen may improve outcomes, study finds

CHICAGO — Patients with high-risk prostate cancer that hasn’t spread typically have two standard treatment paths before them. Remove the prostate surgically or do a combination of radiation therapy and hormone therapy. Now, with the results of a new Phase 3 clinical trial, some oncologists believe a third option may soon be laid on the table: surgery with hormone therapy both before and after the operation. The study, called the PROTEUS trial, found that combining two hormone therapies both befo...